Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 July 2020 | Story Nitha Ramnath | Photo UFS photo archive

The Department of Business Management within the Faculty of Economic and Management Sciences is one of four successful recipients of the Nurturing Emerging Scholars Programme (NESP), which aims to recruit honours graduates who demonstrate academic ability and express an early interest in the possibility of an academic career. 

 “The NESP is a mechanism that addresses a potential shortcoming in the department in the medium to long term. Most of the academics in the department specialise either in entrepreneurship or marketing. As such, the availability of academics with interdisciplinary business knowledge who can teach and do research across the different sub-fields of business management is limited,” says Prof Brownhilder Neneh, Associate Professor in the Department of Business Management.

Once graduates enter the programme – as NESP master’s graduates they form part of a resource pool from which new academics can be recruited. 

Prof Neneh continues: “Considering the imminent retirement of academics in the department, the NESP provides an opportunity to recruit an academic who is able to work with experienced academics, gain experience, and ‘prepare’ the person to become an expert across the different fields in the department.”

“This programme would assist in succession planning within the department as well as training individuals within academia,” she says. 

According to Prof Neneh, access to this funding opportunity will further strengthen and expand the path that the department has embarked upon as far as striving for excellence in teaching, research, and community engagement is concerned, thereby contributing to address key societal challenges. “Appointing an NESP candidate would be an ideal opportunity to recruit an academic who will be able to work with the senior staff and gain experience and teaching/research competencies relevant to the 4IR, and ‘prepare’ the person to become the business management expert in the department,” she says.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept